GK 01
Alternative Names: GK-01Latest Information Update: 15 Sep 2022
At a glance
- Originator Zhiyi Biotechnology
- Class Bacteria
- Mechanism of Action Bacteria replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 25 Aug 2022 Preclinical trials in Unspecified in China (unspecified route) before August 2022 (Zhiyi Biotechnology pipeline, August 2022)